The Journal of Immunology, Vol 151, Issue 4 2032-2040, Copyright © 1993 by American Association of Immunologists

ARTICLES

Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

BS Graham, GS Henderson, YW Tang, X Lu, KM Neuzil and DG Colley
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.

Defining the mechanism for the vaccine-enhanced illness associated with respiratory syncytial virus (RSV) is critical for advancing RSV vaccine development. Previous studies in which infants were vaccinated with formalin-inactivated alum-precipitated whole virus did not protect from RSV infection, and those infected had a high incidence of severe illness. In contrast, previous clinical trials evaluating live attenuated RSV showed no associated vaccine-enhanced illness. We have used a mouse model to explore the immunopathogenesis of RSV infection. In this study cytokine mRNA expression was examined using 32P-labeled oligonucleotide probes in Northern blot analyses of polyA RNA extracted from lungs of mice primed with various vaccine preparations then challenged nasally with live RSV. We have shown that upon challenge, priming of mice with inactivated virus or subunit F glycoprotein induced a pattern of cytokine mRNA expression suggesting a dominant Th2- like lymphocyte response (relative increase in IL-4 mRNA expression). In contrast, challenge of mice primed with live RSV by parenteral or mucosal routes induced a Th1-like pattern of cytokine mRNA expression (relative decrease in IL-4 mRNA expression compared to IFN-gamma mRNA expression). Thus, the formulation and route of delivery of vaccine products can influence the pattern of cytokine expression in lung upon RSV challenge.

This article has been cited by other articles:

				T. R. Johnson, M. E. Rothenberg, and B. S. Graham Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein J. Leukoc. Biol., September 1, 2008; 84(3): 748 - 759. [Abstract] [Full Text] [PDF]

				S. S. Mohapatra and S. Boyapalle Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma Clin. Microbiol. Rev., July 1, 2008; 21(3): 495 - 504. [Abstract] [Full Text] [PDF]

				P. L. Collins and B. S. Graham Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis J. Virol., March 1, 2008; 82(5): 2040 - 2055. [Full Text] [PDF]

				E. M. Castilow, M. R. Olson, D. K. Meyerholz, and S. M. Varga Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial Virus J. Virol., March 1, 2008; 82(5): 2196 - 2207. [Abstract] [Full Text] [PDF]

				N. A. Jewell, N. Vaghefi, S. E. Mertz, P. Akter, R. S. Peebles Jr., L. O. Bakaletz, R. K. Durbin, E. Flano, and J. E. Durbin Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In Vivo J. Virol., September 15, 2007; 81(18): 9790 - 9800. [Abstract] [Full Text] [PDF]

				A. Bukreyev, M. E. Serra, F. R. Laham, G. A. Melendi, S. R. Kleeberger, P. L. Collins, and F. P. Polack The Cysteine-Rich Region and Secreted Form of the Attachment G Glycoprotein of Respiratory Syncytial Virus Enhance the Cytotoxic T-Lymphocyte Response despite Lacking Major Histocompatibility Complex Class I-Restricted Epitopes. J. Virol., June 1, 2006; 80(12): 5854 - 5861. [Abstract] [Full Text] [PDF]

				L. Martinez-Sobrido, N. Gitiban, A. Fernandez-Sesma, J. Cros, S. E. Mertz, N. A. Jewell, S. Hammond, E. Flano, R. K. Durbin, A. Garcia-Sastre, et al. Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector J. Virol., February 1, 2006; 80(3): 1130 - 1139. [Abstract] [Full Text] [PDF]

				R. S. Peebles Jr. and B. S. Graham Pathogenesis of Respiratory Syncytial Virus Infection in the Murine Model Proceedings of the ATS, August 1, 2005; 2(2): 110 - 115. [Abstract] [Full Text] [PDF]

				T. R. Johnson, S. E. Mertz, N. Gitiban, S. Hammond, R. LeGallo, R. K. Durbin, and J. E. Durbin Role for Innate IFNs in Determining Respiratory Syncytial Virus Immunopathology J. Immunol., June 1, 2005; 174(11): 7234 - 7241. [Abstract] [Full Text] [PDF]

				Y. Huang and R. Anderson Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus J. Virol., April 1, 2005; 79(7): 4527 - 4532. [Abstract] [Full Text] [PDF]

				M. Oumouna, J. W. Mapletoft, B. C. Karvonen, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Formulation with CpG Oligodeoxynucleotides Prevents Induction of Pulmonary Immunopathology following Priming with Formalin-Inactivated or Commercial Killed Bovine Respiratory Syncytial Virus Vaccine J. Virol., February 15, 2005; 79(4): 2024 - 2032. [Abstract] [Full Text] [PDF]

				J. A. Rutigliano and B. S. Graham Prolonged Production of TNF-{alpha} Exacerbates Illness during Respiratory Syncytial Virus Infection J. Immunol., September 1, 2004; 173(5): 3408 - 3417. [Abstract] [Full Text] [PDF]

				T. R. Johnson, S. M. Varga, T. J. Braciale, and B. S. Graham V{beta}14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV J. Virol., August 15, 2004; 78(16): 8753 - 8760. [Abstract] [Full Text] [PDF]

				T. R. Johnson, M. N. Teng, P. L. Collins, and B. S. Graham Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV J. Virol., June 1, 2004; 78(11): 6024 - 6032. [Abstract] [Full Text] [PDF]

				P. Aaby, H. Jensen, A. Rodrigues, M.-L. Garly, C. S. Benn, I. M. Lisse, and F. Simondon Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs Int. J. Epidemiol., April 1, 2004; 33(2): 367 - 373. [Abstract] [Full Text] [PDF]

				P. Aaby, H. Jensen, J. Gomes, M. Fernandes, and I. M. Lisse The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study Int. J. Epidemiol., April 1, 2004; 33(2): 374 - 380. [Abstract] [Full Text] [PDF]

				J. A. Rutigliano, T. R. Johnson, T. N. Hollinger, J. E. Fischer, S. Aung, and B. S. Graham Treatment with Anti-LFA-1 Delays the CD8+ Cytotoxic-T-Lymphocyte Response and Viral Clearance in Mice with Primary Respiratory Syncytial Virus Infection J. Virol., March 15, 2004; 78(6): 3014 - 3023. [Abstract] [Full Text] [PDF]

				C. S. Benn, C. Bale, H. Sommerfelt, H. Friis, and P. Aaby Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines? Int. J. Epidemiol., October 1, 2003; 32(5): 822 - 828. [Abstract] [Full Text] [PDF]

				L. G. Bermudez-Humaran, P. Langella, N. G. Cortes-Perez, A. Gruss, R. S. Tamez-Guerra, S. C. Oliveira, O. S. Cardenas, R. Montes de Oca-Luna, and Y. Le Loir Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production Infect. Immun., April 1, 2003; 71(4): 1887 - 1896. [Abstract] [Full Text]

				T. R. Johnson, R. A. Parker, J. E. Johnson, and B. S. Graham IL-13 Is Sufficient for Respiratory Syncytial Virus G Glycoprotein-Induced Eosinophilia After Respiratory Syncytial Virus Challenge J. Immunol., February 15, 2003; 170(4): 2037 - 2045. [Abstract] [Full Text] [PDF]

				P. Aaby, A. Bhuiya, L. Nahar, K. Knudsen, A. de Francisco, and M. Strong The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh Int. J. Epidemiol., February 1, 2003; 32(1): 106 - 115. [Abstract] [Full Text] [PDF]

				F. P. Polack, M. N. Teng, P. L.Collins, G. A. Prince, M. Exner, H. Regele, D. D. Lirman, R. Rabold, S. J. Hoffman, C. L. Karp, et al. A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease J. Exp. Med., September 16, 2002; 196(6): 859 - 865. [Abstract] [Full Text] [PDF]

				M. Chen, K.-F. Hu, B. Rozell, C. Orvell, B. Morein, and P. Liljestrom Vaccination with Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus J. Immunol., September 15, 2002; 169(6): 3208 - 3216. [Abstract] [Full Text] [PDF]

				D. Werling, R. A. Collins, G. Taylor, and C. J. Howard Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus J. Leukoc. Biol., August 1, 2002; 72(2): 297 - 304. [Abstract] [Full Text] [PDF]

				T. R. Johnson, S. Hong, L. Van Kaer, Y. Koezuka, and B. S. Graham NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus J. Virol., March 27, 2002; 76(9): 4294 - 4303. [Abstract] [Full Text] [PDF]

				J. E. Durbin, T. R. Johnson, R. K. Durbin, S. E. Mertz, R. A. Morotti, R. S. Peebles, and B. S. Graham The Role of IFN in Respiratory Syncytial Virus Pathogenesis J. Immunol., March 15, 2002; 168(6): 2944 - 2952. [Abstract] [Full Text] [PDF]

				E. M. Ponnuraj, A. R. Hayward, A. Raj, H. Wilson, and E. A. F. Simoes Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine J. Gen. Virol., November 1, 2001; 82(11): 2663 - 2674. [Abstract] [Full Text] [PDF]

				J Hull, A Thomson, and D Kwiatkowski Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families Thorax, December 1, 2000; 55(12): 1023 - 1027. [Abstract] [Full Text]

				G. P. Bembridge, N. Rodriguez, R. Garcia-Beato, C. Nicolson, J. A. Melero, and G. Taylor DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation J. Gen. Virol., October 1, 2000; 81(10): 2519 - 2523. [Abstract] [Full Text]

				A. Bukreyev, S. S. Whitehead, C. Prussin, B. R. Murphy, and P. L. Collins Effect of Coexpression of Interleukin-2 by Recombinant Respiratory Syncytial Virus on Virus Replication, Immunogenicity, and Production of Other Cytokines J. Virol., August 1, 2000; 74(15): 7151 - 7157. [Abstract] [Full Text]

				J. SCHWARZE, G. CIESLEWICZ, A. JOETHAM, T. IKEMURA, M. J. MAKELA, A. DAKHAMA, L. D. SHULTZ, M. C. LAMERS, and E. W. GELFAND Critical Roles for Interleukin-4 and Interleukin-5 during Respiratory Syncytial Virus Infection in the Development of Airway Hyperresponsiveness after Airway Sensitization Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 380 - 386. [Abstract] [Full Text] [PDF]

				A. R. Falsey and E. E. Walsh Respiratory Syncytial Virus Infection in Adults Clin. Microbiol. Rev., July 1, 2000; 13(3): 371 - 384. [Abstract] [Full Text] [PDF]

				R. A. Tripp, L. Jones, and L. J. Anderson Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse J. Virol., July 1, 2000; 74(13): 6227 - 6229. [Abstract] [Full Text]

				R. A. Tripp, L. Jones, L. J. Anderson, and M. P. Brown CD40 Ligand (CD154) Enhances the Th1 and Antibody Responses to Respiratory Syncytial Virus in the BALB/c Mouse J. Immunol., June 1, 2000; 164(11): 5913 - 5921. [Abstract] [Full Text] [PDF]

				R. A. Tripp, D. Moore, J. Winter, and L. J. Anderson Respiratory Syncytial Virus Infection and G and/or SH Protein Expression Contribute to Substance P, Which Mediates Inflammation and Enhanced Pulmonary Disease in BALB/c Mice J. Virol., February 15, 2000; 74(4): 1614 - 1622. [Abstract] [Full Text]

				J. W. Simecka, R. J. Jackson, H. Kiyono, and J. R. McGhee Mucosally Induced Immunoglobulin E-Associated Inflammation in the Respiratory Tract Infect. Immun., February 1, 2000; 68(2): 672 - 679. [Abstract] [Full Text] [PDF]

				T. R. Johnson and B. S. Graham Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism J. Virol., October 1, 1999; 73(10): 8485 - 8495. [Abstract] [Full Text] [PDF]

				J. H. ABERLE, S. W. ABERLE, M. N. DWORZAK, C. W. MANDL, W. REBHANDL, G. VOLLNHOFER, M. KUNDI, and T. POPOW-KRAUPP Reduced Interferon-gamma Expression in Peripheral Blood Mononuclear Cells of Infants with Severe Respiratory Syncytial Virus Disease Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1263 - 1268. [Abstract] [Full Text]

				R. A. Tripp, D. Moore, L. Jones, W. Sullender, J. Winter, and L. J. Anderson Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice J. Virol., September 1, 1999; 73(9): 7099 - 7107. [Abstract] [Full Text]

				A. Srikiatkhachorn, W. Chang, and T. J. Braciale Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent J. Virol., August 1, 1999; 73(8): 6590 - 6597. [Abstract] [Full Text]

				R. Weltzin and T. P. Monath Intranasal Antibody Prophylaxis for Protection against Viral Disease Clin. Microbiol. Rev., July 1, 1999; 12(3): 383 - 393. [Abstract] [Full Text] [PDF]

				G. Gudmundsson, M. M. Monick, and G. W. Hunninghake Viral Infection Modulates Expression of Hypersensitivity Pneumonitis J. Immunol., June 15, 1999; 162(12): 7397 - 7401. [Abstract] [Full Text] [PDF]

				J. B. Domachowske and H. F. Rosenberg Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment Clin. Microbiol. Rev., April 1, 1999; 12(2): 298 - 309. [Abstract] [Full Text] [PDF]

				A. Bukreyev, S. S. Whitehead, N. Bukreyeva, B. R. Murphy, and P. L. Collins Interferon gamma  expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity PNAS, March 2, 1999; 96(5): 2367 - 2372. [Abstract] [Full Text] [PDF]

				J. Schwarze, G. Cieslewicz, E. Hamelmann, A. Joetham, L. D. Shultz, M. C. Lamers, and E. W. Gelfand IL-5 and Eosinophils Are Essential for the Development of Airway Hyperresponsiveness Following Acute Respiratory Syncytial Virus Infection J. Immunol., March 1, 1999; 162(5): 2997 - 3004. [Abstract] [Full Text] [PDF]

				S. S. Whitehead, C.-Y. Firestone, R. A. Karron, J. E. Crowe Jr., W. R. Elkins, P. L. Collins, and B. R. Murphy Addition of a Missense Mutation Present in the L Gene of Respiratory Syncytial Virus (RSV) cpts530/1030 to RSV Vaccine Candidate cpts248/404 Increases Its Attenuation and Temperature Sensitivity J. Virol., February 1, 1999; 73(2): 871 - 877. [Abstract] [Full Text]

				R. A. Tripp and L. J. Anderson Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine J. Virol., November 1, 1998; 72(11): 8971 - 8975. [Abstract] [Full Text] [PDF]

				X. Li, S. Sambhara, C. X. Li, M. Ewasyshyn, M. Parrington, J. Caterini, O. James, G. Cates, R.-P. Du, and M. Klein Protection against Respiratory Syncytial Virus Infection by DNA Immunization J. Exp. Med., August 17, 1998; 188(4): 681 - 688. [Abstract] [Full Text] [PDF]

				R. A. Dudas and R. A. Karron Respiratory Syncytial Virus Vaccines Clin. Microbiol. Rev., July 1, 1998; 11(3): 430 - 439. [Abstract] [Full Text] [PDF]

				D. I. Blyth, M. S. Pedrick, T. J. Savage, H. Bright, J. E. Beesley, and S. Sanjar Induction, Duration, and Resolution of Airway Goblet Cell Hyperplasia in a Murine Model of Atopic Asthma: Effect of Concurrent Infection with Respiratory Syncytial Virus and Response to Dexamethasone Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 38 - 54. [Abstract] [Full Text]

				T. E. Sparer, S. Matthews, T. Hussell, A. J. Rae, B. Garcia-Barreno, J. A. Melero, and P. J.M. Openshaw Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia J. Exp. Med., June 1, 1998; 187(11): 1921 - 1926. [Abstract] [Full Text] [PDF]

				G. P. Bembridge, J. A. Lopez, R. Cook, J. A. Melero, and G. Taylor Recombinant Vaccinia Virus Coexpressing the F Protein of Respiratory Syncytial Virus (RSV) and Interleukin-4 (IL-4) Does Not Inhibit the Development of RSV-Specific Memory Cytotoxic T Lymphocytes, whereas Priming Is Diminished in the Presence of High Levels of IL-2 or Gamma Interferon J. Virol., May 1, 1998; 72(5): 4080 - 4087. [Abstract] [Full Text] [PDF]

				T. R. Johnson, J. E. Johnson, S. R. Roberts, G. W. Wertz, R. A. Parker, and B. S. Graham Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge J. Virol., April 1, 1998; 72(4): 2871 - 2880. [Abstract] [Full Text] [PDF]

				A. Srikiatkhachorn and T. J. Braciale Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection J. Exp. Med., August 4, 1997; 186(3): 421 - 432. [Abstract] [Full Text] [PDF]

				R L Smyth, J N Fletcher, H M Thomas, and C A Hart Immunological responses to respiratory syncytial virus infection in infancy Arch. Dis. Child., March 1, 1997; 76(3): 210 - 214. [Abstract] [Full Text]

				C. Hall Prospects for a respiratory syncytial virus vaccine Science, September 2, 1994; 265(5177): 1393 - 1394. [PDF]

				E. Gemmell and G. J. Seymour Cytokines and T Cell Switching Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(3): 249 - 279. [Abstract] [Full Text] [PDF]